What is the Fiscal Year for PaxMedica?
Date: November 14, 2026
PaxMedica's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Tarrytown, New York, United States
Industry
Healthcare, Biotechnology Research Services
Stock Symbol
PXMD
Website
https://paxmedica.comDescription
PaxMedica (OTCQB: PXMD) is a forward-thinking clinical-stage biopharmaceutical company, unwavering in its dedication to advancing innovative therapies for individuals and families impacted by neurodevelopmental disorders. With a primary focus on Autism Spectrum Disorder (ASD), PaxMedica is committed to developing groundbreaking treatments that address the unmet medical needs of those affected by this complex condition. Our team of dedicated experts and scientists collaborates passionately to bring meaningful advancements to the field, aiming to provide relief from the core symptoms of autism and improve the overall quality of life for those affected. We believe in the power of scientific innovation, and we are committed to making a real difference for individuals with ASD and their families. Join us on our mission to bring about transformative change in the world of neurodevelopmental disorders.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like PaxMedica and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.